|Last Price||Today's Change||52-Week Range||Trading Volume|
|70.01||-0.15 (-0.21%)||51.37 - 71.60||6.2 million (Below Avg)|
Market data as of 4:03PM 07/31/15. Quotes are delayed by at least 15 min.
European Medicines Agency Validates and Grants Accelerated Assessment of Marketing Authorization Application for Empliciti (elotuzumab) For the Treatment of Multiple Myeloma in Patients Who Have Received One or More Prior Therapies
07/27/2015 7:00 AM ET
TECHNIVIE™ (ombitasvir, paritaprevir, and ritonavir tablets) Receives FDA Approval as the First and Only All-Oral, Interferon-Free Treatment for Genotype 4 Chronic Hepatitis C in the U.S.
07/24/2015 2:00 PM ET
AbbVie Reports Second-Quarter 2015 Financial Results
07/24/2015 7:53 AM ET